Bayesian Capital Management’s NCR Voyix VYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,500
Closed -$207K 543
2025
Q3
$207K Buy
16,500
+4,000
+32% +$52.7K 0.04% 458
2025
Q2
$147K Sell
12,500
-16,060
-56% -$162K 0.02% 482
2025
Q1
$278K Sell
28,560
-17,500
-38% -$205K 0.05% 407
2024
Q4
$637K Buy
+46,060
New +$639K 0.08% 321
2023
Q3
Sell
-41,239
Closed -$638K 1032
2023
Q2
$638K Buy
41,239
+4,401
+12% +$63.5K 0.07% 354
2023
Q1
$533K Sell
36,838
-18,419
-33% -$283K 0.07% 373
2022
Q4
$794K Sell
55,257
-132,682
-71% -$1.76M 0.12% 230
2022
Q3
$2.19M Buy
187,939
+108,232
+136% +$1.99M 0.44% 43
2022
Q2
$1.52M Buy
79,707
+36,023
+82% +$768K 0.28% 88
2022
Q1
$1.08M Buy
43,684
+34,882
+396% +$857K 0.16% 194
2021
Q4
$217K Buy
+8,802
New +$223K 0.07% 307
2020
Q1
Sell
-25,917
Closed -$559K 1001
2019
Q4
$559K Buy
25,917
+15,485
+148% +$301K 0.1% 288
2019
Q3
$202K Buy
+10,432
New +$202K 0.04% 448
2017
Q2
Sell
-12,479
Closed -$350K 612
2017
Q1
$350K Sell
12,479
-24,939
-67% -$683K 0.17% 225
2016
Q4
$931K Buy
+37,418
New +$840K 0.23% 145

Other funds holding VYX

Bayesian Capital Management's VYX Position: Q4 2025 in Review

Bayesian Capital Management sold out of NCR Voyix (VYX) in Q4 2025, closing a stake of 16,500 shares — an estimated $207K sold.

Bayesian Capital Management first reported a position in VYX in Q4 2016 and held it in 15 quarters. The position peaked at $2.19M in Q3 2022. 296 funds tracked by Wall St. Rank hold VYX as of Q4 2025.

  • Bayesian Capital Management reported no remaining NCR Voyix position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 16,500 NCR Voyix shares in Q4 2025, an estimated $207K.
  • Bayesian Capital Management first reported a position in NCR Voyix in Q4 2016 and held it in 15 quarters.
  • Bayesian Capital Management's NCR Voyix position peaked at $2.19M in Q3 2022.
  • 296 funds tracked by Wall St. Rank held NCR Voyix as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.